MedPath

Study compares sevoflurane and propofol when used individually as inducing agents for insertion of supraglottic airway device.

Phase 3
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2022/06/043227
Lead Sponsor
MAJ DR AKSHAY CHANDRASHEKAR GUNDALLI
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

A. 140 ASA Grade I or II patients, between 20 and 70 years of age, undergoing general anaesthesia for short surgery ( <3 hrs) were enrolled in the study.

B. Willing for valid consent.

Exclusion Criteria

1.If they were predicted to have a difficult airway (Mallampatti Grade III or IV), ASA 3 and more, had a history of GI reflux, were receiving anti-epileptic medication, had a history of cardio-vascular, renal, hypertensive disease or known allergy to any anaesthetic.

2.Patients who are unable to open their mouth, supraglottic blockage.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath